Free tool
FAERS Monitor: Cortef
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 008697 or its brand name (Cortef, Hydrocortisone). Reports on generic versions are filed under their own applications.
Reports
70,802
Serious
58,283
82% of reports
Hospitalization
29,929
Death reported
10,246
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use9,850
- drug ineffective7,835
- fatigue6,470
- condition aggravated5,622
- nausea5,378
- rash5,086
- headache4,757
- diarrhoea4,750
- pain4,696
- dyspnoea4,614
- arthralgia4,551
- pyrexia4,192
- vomiting4,181
- pruritus3,881
- malaise3,855
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 493 |
| 2005 | 606 |
| 2006 | 574 |
| 2007 | 610 |
| 2008 | 646 |
| 2009 | 793 |
| 2010 | 913 |
| 2011 | 1,161 |
| 2012 | 1,881 |
| 2013 | 1,620 |
| 2014 | 1,888 |
| 2015 | 2,562 |
| 2016 | 3,006 |
| 2017 | 3,527 |
| 2018 | 5,022 |
| 2019 | 4,494 |
| 2020 | 5,500 |
| 2021 | 5,659 |
| 2022 | 6,276 |
| 2023 | 6,249 |
| 2024 | 6,572 |
| 2025 | 6,336 |
| 2026 | 4,410 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,983,357 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| condition aggravatedSignal | 5,622 | 5.6 | 5.4 | 21,031 |
| pyrexiaSignal | 4,192 | 3.6 | 3.5 | 8,024 |
| rashSignal | 5,086 | 3.5 | 3.4 | 9,141 |
| off label useSignal | 9,850 | 3.4 | 3.3 | 16,920 |
| arthralgiaSignal | 4,551 | 3.3 | 3.2 | 7,261 |
| pruritusSignal | 3,881 | 3.0 | 2.9 | 5,287 |
| vomitingSignal | 4,181 | 2.7 | 2.6 | 4,376 |
| malaiseSignal | 3,855 | 2.6 | 2.5 | 3,925 |
| fatigueSignal | 6,470 | 2.5 | 2.4 | 5,889 |
| dyspnoeaSignal | 4,614 | 2.4 | 2.4 | 3,968 |
| painSignal | 4,696 | 2.3 | 2.2 | 3,451 |
| headacheSignal | 4,757 | 2.3 | 2.2 | 3,431 |
| diarrhoeaSignal | 4,750 | 2.2 | 2.1 | 3,163 |
| nauseaSignal | 5,378 | 2.0 | 2.0 | 2,881 |
| drug ineffective | 7,835 | 1.8 | 1.7 | 2,786 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.